We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-15.83%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.76B
AUM Growth
-$3.06B
Cap. Flow
-$2.1B
Cap. Flow %
-55.74%
Top 10 Hldgs %
30.37%
Holding
139
New
24
Increased
31
Reduced
30
Closed
45

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$74.9M
2
MCHP icon
Microchip Technology
MCHP
+$72.9M
3
BLK icon
Blackrock
BLK
+$68.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$61.5M
5
ALGN icon
Align Technology
ALGN
+$59.9M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$172M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$161M
3
AGN
Allergan plc
AGN
+$131M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$123M
5
PCRX icon
Pacira BioSciences
PCRX
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 51.45%
2 Technology 16.06%
3 Financials 5.24%
4 Communication Services 3.47%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
1
CALL
iShares S&P 100 ETF
OEF
$20.2B
$175M 4.64%
+4,470,900
New +$538M
GDDY icon
2
GoDaddy
GDDY
$11.8B
$145M 3.85%
2,210,808
+1,095,607
+98% +$74.9M
ELV icon
3
Elevance Health
ELV
$84.6B
$119M 3.15%
451,421
-80,269
-15% -$22.1M
ARNA
4
DELISTED
Arena Pharmaceuticals Inc
ARNA
$117M 3.12%
3,014,672
+285,117
+10% +$11.2M
HUM icon
5
Humana
HUM
$48B
$117M 3.11%
408,093
+67,083
+20% +$21.3M
PEN icon
6
Penumbra
PEN
$12.5B
$110M 2.93%
902,898
+177,497
+24% +$23.8M
CI icon
7
CALL
Cigna
CI
$76.7B
$105M 2.8%
554,300
-857,900
-61% -$179M
ESPR
8
DELISTED
Esperion Therapeutics
ESPR
$86.4M 2.3%
1,879,003
-91,131
-5% -$4.39M
ONCE
9
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$85.5M 2.27%
2,183,393
+1,323,913
+154% +$57.4M
EW icon
10
Edwards Lifesciences
EW
$48.7B
$82.8M 2.2%
1,622,481
+54,465
+3% +$2.76M
ABT icon
11
Abbott
ABT
$176B
$82.8M 2.2%
1,144,699
-82,361
-7% -$5.79M
CRM icon
12
Salesforce
CRM
$134B
$82.4M 2.19%
601,699
+54,013
+10% +$7.43M
AMZN icon
13
Amazon
AMZN
$2.61T
$82.2M 2.18%
1,094,560
+447,700
+69% +$37.2M
PYPL icon
14
PayPal
PYPL
$48.8B
$80.2M 2.13%
953,584
+434,680
+84% +$36.2M
BPMC
15
DELISTED
Blueprint Medicines
BPMC
$79.3M 2.11%
1,470,436
+30,398
+2% +$1.85M
MYOK
16
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$75.2M 2%
1,538,131
-340,778
-18% -$18.8M
MCHP icon
17
Microchip Technology
MCHP
$46B
$74.3M 1.97%
+2,064,984
New +$72.9M
MSFT icon
18
Microsoft
MSFT
$2.88T
$70.5M 1.87%
694,274
+346,164
+99% +$37.1M
ZBH icon
19
Zimmer Biomet
ZBH
$17.1B
$70.4M 1.87%
698,678
-86,114
-11% -$9.68M
GOOGL icon
20
Alphabet (Google) Class A
GOOGL
$4.23T
$69.1M 1.84%
1,321,820
-446,600
-25% -$24.1M
AERI
21
DELISTED
Aerie Pharmaceuticals
AERI
$68.4M 1.82%
1,893,935
-364,508
-16% -$17.1M
BLK icon
22
Blackrock
BLK
$162B
$65.5M 1.74%
+166,775
New +$68.3M
BOLD
23
DELISTED
Audentes Therapeutics, Inc
BOLD
$64.4M 1.71%
3,021,259
+1,467,120
+94% +$37.9M
UNH icon
24
UnitedHealth
UNH
$395B
$60M 1.59%
240,885
+15,092
+7% +$3.99M
TMO icon
25
Thermo Fisher Scientific
TMO
$196B
$58.7M 1.56%
+262,107
New +$61.5M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q4 2018 Portfolio in Review

As of Q4 2018, PFM Health Sciences held 139 positions worth $3.76B, down 45% from $6.83B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences withdrew a net $2.1B in Q4 2018, closing 45 positions and reducing 30 holdings. Its most notable exit was Viatris, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Microchip Technology worth $74.3M.

  • PFM Health Sciences's largest Q4 2018 buy was Microchip Technology: 2,064,984 shares worth $74.3M.
  • PFM Health Sciences added most to GoDaddy in Q4 2018, an estimated $74.9M increase.
  • PFM Health Sciences's biggest Q4 2018 reduction was Pacira BioSciences, cutting an estimated $106M.
  • PFM Health Sciences fully exited Viatris in Q4 2018, selling an estimated $172M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $3.76B portfolio in Q4 2018.
  • PFM Health Sciences opened 24 new positions and closed 45 in Q4 2018.
  • PFM Health Sciences's portfolio value fell 45% quarter-over-quarter to $3.76B.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.